Lakefront Biotherapeutics N.V.
LKFT | NASDAQ
$31.96
-$0.32 (-0.99%)
Nov 2, 2026, 2:34 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 12.12M | 6.48M | 900.82M | 71.16M | 65.29M | 74.98M | 75.5M | 59.85M | 77.87M | 62.43M | -209.12M | 120.03M | 60.05M | 58.57M | 90.11M | 136.2M | 137.61M | 136.35M | 166.99M | 64.19M |
Cost of Revenue | 34.64M | 4.8M | 455K | 10.85M | 4.71M | 13.73M | 112.93M | 93.06M | 90.17M | -261.3M | 84.43M | 317.88M | 56.18M | 52.56M | 24.49M | 116.94M | 35.74M | 102.83M | 114.65M | 109.73M |
Gross Profit | -22.52M | 1.68M | 900.37M | 60.32M | 60.58M | 61.25M | -37.43M | -33.22M | -12.3M | 323.73M | -124.7M | -197.85M | 3.87M | 6.02M | 65.62M | 19.26M | 104.42M | 33.51M | 52.33M | -45.53M |
Operating Income | -43.5M | -63.7M | 758.8M | -41.67M | -57.03M | -158.71M | -81.05M | -54.31M | -38.18M | -33.13M | -69.31M | -30.23M | -13.51M | -53.18M | 4M | -37.58M | -76.33M | -21.15M | 10.15M | -78.2M |
Interest Income | 12.14M | 13.56M | n/a | n/a | 9.95M | 12.56M | 18.68M | 20.48M | 24.36M | 24.95M | 27.69M | 17.05M | 33.62M | n/a | 7.9M | 3.9M | n/a | n/a | n/a | n/a |
Pretax Income | 2.04M | 13.96M | 783.16M | -221.49M | -104.42M | -156.37M | 19.6M | -49.14M | 4.09M | 22.94M | -62.02M | 25.73M | 16.79M | -47.89M | -63.3M | 22.25M | -18.22M | -11.59M | 19.09M | -64.46M |
Net Income | 2.11M | 14.49M | 782.15M | -202.11M | -105.75M | -153.4M | 25.31M | -50.43M | 8.99M | 90.22M | 157.56M | 25.83M | 5.1M | 23.21M | -207.21M | 21.55M | -19.03M | -13.31M | 16.35M | -64.61M |
Selling & General & Admin | 22.88M | 35.51M | 2.94M | 46.42M | 18.8M | 43.8M | 40.01M | 29.27M | 33.14M | 31.09M | 51.35M | 60.57M | 30.89M | 26.69M | 82.32M | 68.68M | 69.65M | 62.34M | 59.57M | 45.45M |
Research & Development | 25.54M | 30.96M | 107.51M | 73.88M | 95.28M | 182.75M | 97.19M | 93.05M | 73.61M | 72.32M | 70.89M | 100.31M | 56.18M | 51.86M | 125.23M | 114.55M | 122.66M | 99.92M | 113.69M | 109.2M |
Other Expenses | -27.44M | -1.08M | 31.11M | -18.32M | 3.54M | -6.59M | -111.91M | -101.22M | -80.86M | 253.44M | -346.48M | -328.5M | -69.69M | -58.33M | n/a | -126.39M | -75.65M | -107.6M | -131.07M | -121.98M |
Operating Expenses | 20.98M | 65.39M | 141.57M | 101.99M | 117.61M | 219.96M | 25.29M | 21.09M | 25.89M | 356.86M | -224.24M | -167.62M | 17.38M | 20.21M | 207.56M | 56.84M | 116.65M | 54.66M | 42.18M | 32.67M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 844K | n/a | n/a | 588K | n/a | 2.47M | 3.34M |
Selling & Marketing Expenses | 2.77M | 2.77M | -3.01M | 3.88M | -3.65M | 4.17M | 7.02M | 3.09M | 4.18M | 2.91M | 82.47M | 29.89M | 417K | 1.02M | 101.83M | 34.31M | 42.02M | 28.98M | 23.34M | 17.66M |
Cost & Expenses | 55.62M | 70.18M | 142.02M | 112.83M | 122.32M | 233.69M | 138.22M | 114.15M | 116.06M | 95.56M | -139.82M | 150.26M | 73.56M | 72.77M | -172.91M | 173.78M | 213.94M | 157.49M | 156.84M | 142.39M |
Income Tax Expense | 130K | 70K | 666K | -17.5M | 26K | -1.81M | -95.8K | -561.58K | -571K | -573.63K | -2.53M | -592.19K | 12.92M | -182.53K | -2.66M | 694K | 812K | 1.72M | 2.74M | 157K |
Shares Outstanding (Basic) | 73.71M | 65.87M | 65.9M | 65.9M | 65.9M | 65.84M | 87.39M | 68.14M | 127.11M | 252.79M | 178.94M | 66.27M | 86.23M | 137.45M | 223.76M | 65.83M | 64.91M | 66.55M | 65.41M | 65.53M |
Shares Outstanding (Diluted) | 66.93M | 65.87M | 65.9M | 65.9M | 65.9M | 65.84M | 29.84K | 65.94M | 66.24M | 65.85M | -88.95K | 66.27M | 65.62M | 66.31M | -64.45K | 65.83M | 64.91M | 66.55M | 65.41M | 65.53M |
EPS (Basic) | 0.03 | 0.22 | 11.87 | -3.07 | -1.60 | -2.33 | 0.29 | -0.74 | 0.07 | 0.36 | -0.88 | 0.39 | 0.06 | -0.17 | -0.92 | 0.33 | -0.29 | -0.20 | 0.25 | -0.99 |
EPS (Diluted) | 0.03 | 0.22 | 11.87 | -3.07 | -1.60 | -2.33 | 0.29 | -0.74 | 0.07 | 0.36 | -0.88 | 0.39 | 0.06 | -0.17 | -0.93 | 0.33 | -0.29 | -0.20 | 0.25 | -0.99 |
EBITDA | -35.27M | 13.96M | 560.5M | 2.42M | -101.12M | -158.71M | -81.05M | -61.45M | -45.58M | -42.94M | -35.04M | -27.66M | -4.22M | -10.02M | -121.37M | -31.7M | 172.57M | -15.63M | 12.24M | -70.14M |
EBIT | -43.5M | 13.96M | 560.5M | 2.42M | -101.12M | -158.71M | -81.05M | -61.45M | -45.58M | -42.94M | -66.16M | -27.66M | -13.51M | -14.2M | -141.94M | -37.58M | 138.97M | -21.15M | 10.17M | -78.2M |
Depreciation & Amortization | 8.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.83M | 31.12M | -933K | 9.28M | 4.18M | 20.57M | 5.88M | 33.6M | 5.52M | 2.08M | 8.05M |
Add to Watchlist
Select watchlists to add or remove LKFT